Aims: Several prospective studies have reported that higher visit-to-visit blood pressure variability (BPV) is associated with atrial fibrillation (AF). However, no studies have investigated the association between day-to-day BPV assessed by home blood pressure measurement and the development of AF. Methods and results: A total of 2829 community-dwelling Japanese aged ≥40 years without prior AF were followed up for 10 years (2007–17). Day-to-day home BPV [defined as coefficient of variation (CoV) of home systolic blood pressure (SBP) for 28 days] was categorized into four groups according to the quartiles: Q1, ≤ 4.64%; Q2, 4.65–5.70%; Q3, 5.71–7.01%; Q4, ≥ 7.02%. The hazard ratios for developing AF were estimated using a Cox proportional hazards model. During the follow-up period, 134 participants developed new-onset AF. The crude incidence rates of AF increased significantly with higher CoV levels of home SBP: 2.1, 4.9, 5.2, and 8.8 per 1000 person-years in the first, second, third, and fourth quartiles, respectively (P for trend < 0.01). After adjusting for potential confounders, increased CoV levels of home SBP were associated significantly with a higher risk of AF (P for trend = 0.02). The participants in the highest quartile of CoV had a 2.20-fold (95% confidence intervals: 1.18–4.08) increased risk of developing AF compared with those in the lowest quartile. Conclusion: The present findings suggest that increased day-to-day home BPV levels are associated with a higher risk of the development of AF in a general Japanese population.
Aims: P-wave indices (PWIs) are associated with incidence of atrial fibrillation (AF) and extent of left atrial fibrosis. We investigated associations of P-wave duration and P-wave terminal force in V1 (PTFV1) with incidence of AF and extent of atrial fibrosis in a Japanese community. Methods and results: Participants were classified based on P-wave duration in lead II (≥120 and <120 ms) or PTFV1 (≥4000 and <4000 μV*ms). Fibrosis in the left atrial posterior wall was pathologically evaluated in 133 autopsied cases with clinical information. Hazard ratios for AF were estimated using a Cox proportional hazards model. Differences in the extent of left atrial fibrosis between P-wave index categories were tested by analysis of covariance. A total of 2907 community-dwelling individuals aged ≥40 years without prior AF were followed for 10 years. Participants with prolonged P-wave duration or elevated PTFV1 were older and had more cardiovascular risk factors. During follow-up, 140 participants developed AF. Unadjusted incidence rates of AF were significantly higher in participants with P-wave duration ≥120 ms or PTFV1 ≥ 4000 μV*ms than in those with values below these cut-offs (4.6 vs. 10.6, and 4.7 vs. 14.4 per 1000 person-years, respectively; both P < 0.001). Participants with P-wave duration ≥120 ms had a significantly higher age- and sex-adjusted geometric mean percentage of left atrial fibrosis than those with P-wave duration <120 ms (P = 0.04). Conclusion: P-wave duration and PTFV1 are useful indicators for assessing AF risk. Furthermore, prolonged P-wave duration reflects the extent of left atrial fibrosis.